المؤلفون: Bus, P, Lemmens, Valery, van Oijen, MG, Creemers, GJM, Nieuwenhuijzen, GA, van Baal, JW, Siersema, PD (Peter)

المساهمون: Public Health, Gastroenterology & Hepatology

المصدر: Journal of Surgical Oncology, 109(5), 465-471. Wiley-Liss Inc.

مصطلحات موضوعية: SDG 3 - Good Health and Well-being

URL الوصول: https://explore.openaire.eu/search/publication?articleId=narcis______::62f2c4f299c001e96a88c04c846d4ebe
https://pure.eur.nl/en/publications/7d5e659c-26b4-4783-81b1-29b273c41599

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bakkers C; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Rovers KP; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Rijken A; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Simkens GAAM; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Bonhof CS; Center of Research on Psychological and Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., Nienhuijs SW; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Burger JWA; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands., Creemers GJM; Department of Medical Oncology, Catharina Cancer Institute, Eindhoven, The Netherlands., Brandt-Kerkhof ARM; Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., Tuynman JB; Department of Surgery, Amsterdam University Medical Centers, VUMC, Amsterdam, The Netherlands., Aalbers AGJ; Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands., Wiezer MJ; Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands., de Reuver PR; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., van Grevenstein WMU; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands., Hemmer PHJ; Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands., Punt CJA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Tanis PJ; Department of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Mols F; Center of Research on Psychological and Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands. ignace.d.hingh@catharinaziekenhuis.nl.; GROW - School for Oncology and Development Biology, Maastricht University, Maastricht, The Netherlands. ignace.d.hingh@catharinaziekenhuis.nl.

مؤلفون مشاركون: Dutch Peritoneal Oncology Group and the Dutch Colorectal Cancer Group

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2023 May; Vol. 30 (5), pp. 2678-2688. Date of Electronic Publication: 2023 Feb 08.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Peritoneal Neoplasms*/secondary , Colorectal Neoplasms*/pathology , Hyperthermia, Induced*, Humans ; Hyperthermic Intraperitoneal Chemotherapy ; Cytoreduction Surgical Procedures ; Combined Modality Therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Patient Reported Outcome Measures ; Survival Rate

المؤلفون: van den Berg K; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Schaap DP; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Voogt ELK; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Buffart TE; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centres, Amsterdam, the Netherlands., Verheul HMW; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., de Groot JWB; Department of Medical Oncology, Isala Oncology Centre, Zwolle, the Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Melenhorst J; Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht, the Netherlands., de Wilt JHW; Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands., van Westreenen HL; Department of Surgery, Isala, Zwolle, the Netherlands., Aalbers AGJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van 't Veer M; Department of Research and Education, Catharina Hospital, Eindhoven, the Netherlands., Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Vincent J; Department of Medical Oncology, Elkerliek Hospital, Helmond, the Netherlands., Simkens LHJ; Department of Medical Oncology, Maxima Medical Centre, Veldhoven, the Netherlands., Peters NAJB; Department of Medical Oncology, St. Jans Hospital, Weert, the Netherlands., Berbée M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Werter IM; Department of Medical Oncology, Rijnstate Hospital, Arnhem, the Netherlands., Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Peulen HMU; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands., van Lijnschoten IG; Department of Pathology, PAMM Laboratory for Pathology and Medical Microbiology, Eindhoven, the Netherlands., Roef MJ; Department of Nuclear Medicine, Catharina Hospital, Eindhoven, the Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Bloemen JG; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Willems JMWE; Department of Medical Oncology, Anna Hospital, Geldrop, the Netherlands., Creemers GJM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, the Netherlands., Rutten HJT; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands. pim.burger@catharinaziekenhuis.nl.

المصدر: BMC cancer [BMC Cancer] 2022 Sep 06; Vol. 22 (1), pp. 957. Date of Electronic Publication: 2022 Sep 06.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Second Primary*/pathology , Rectal Neoplasms*/pathology, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/analogs & derivatives ; Chemoradiotherapy/methods ; Clinical Trials, Phase II as Topic ; Fluorouracil/therapeutic use ; Humans ; Leucovorin ; Multicenter Studies as Topic ; Neoadjuvant Therapy/methods ; Neoplasm Staging ; Organoplatinum Compounds ; Quality of Life ; Treatment Outcome

SCR Protocol: FOLFOXIRI protocol

المؤلفون: Voogt ELK; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands. eva.voogt@catharinaziekenhuis.nl., van Zoggel DMGI; Department of Surgery, Isala, Zwolle, The Netherlands., Kusters M; Department of Surgery, Amsterdam University Medical Centres, Location VUmc, Amsterdam, The Netherlands., Nieuwenhuijzen GAP; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Bloemen JG; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Peulen HMU; Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands., Creemers GJM; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands., van Lijnschoten G; Pathology Department, PAMM Laboratory for Pathology and Medical Microbiology, Eindhoven, The Netherlands., Nederend J; Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands., Roef MJ; Department of Nuclear Medicine, Catharina Hospital, Eindhoven, The Netherlands., Burger JWA; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Rutten HJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

المصدر: Annals of surgical oncology [Ann Surg Oncol] 2020 Sep; Vol. 27 (9), pp. 3503-3513. Date of Electronic Publication: 2020 Mar 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Induction Chemotherapy*/methods , Neoadjuvant Therapy*/methods , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/mortality , Neoplasm Recurrence, Local*/radiotherapy , Neoplasm Recurrence, Local*/surgery , Rectal Neoplasms*/drug therapy , Rectal Neoplasms*/mortality , Rectal Neoplasms*/radiotherapy , Rectal Neoplasms*/surgery, Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Capecitabine/administration & dosage ; Combined Modality Therapy ; Female ; Fluorouracil/administration & dosage ; Humans ; Leucovorin/administration & dosage ; Male ; Margins of Excision ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin/administration & dosage ; Proctectomy/methods ; Reoperation ; Retrospective Studies ; Survival Analysis ; Treatment Outcome

SCR Protocol: Folfox protocol

المؤلفون: Kwakman JJM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam., Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Eindhoven., van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo., Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda., Creemers GJM; Department of Medical Oncology, Catharina Hospital, Eindhoven., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar., Los M; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein., van Alphen RJ; Department of Medical Oncology, TweeSteden Hospital, Tilburg., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden., Muller EW; Department of Medical Oncology, Slingeland Hospital, Doetinchem., van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Hilversum., van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Arnhem., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht., Mol L; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen., van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands., Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Jun 01; Vol. 28 (6), pp. 1288-1293.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Capecitabine/*therapeutic use , Colorectal Neoplasms/*drug therapy , Oxonic Acid/*therapeutic use , Tegafur/*therapeutic use, Aged ; Drug Combinations ; Female ; Humans ; Male